Načítá se...
Proteasome inhibition, the pursuit of new cancer therapeutics, and the adaptor molecule p130Cas
Current interest in proteasome inhibitors for cancer therapy has stimulated considerable research efforts to identify the molecular pathway to their cytotoxicity with a view to identifying the mechanisms of sensitivity and resistance as well as informing the development of new drugs. Zhao and Vuori...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3203852/ https://ncbi.nlm.nih.gov/pubmed/22034840 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1741-7007-9-72 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|